Skip to content

PolitiKit

Terry Creighton's lobbying: the clients they represent and every meeting they've reported since November 2021.

← Lobbying

Consultant lobbyist

Terry Creighton

Meetings this Parliament
8
Since Nov 2021
8
Active registrations
1

Reported meetings

    • Ed Morgan · Director General, Health Canada (HC)
    • Robyn Brake · Director, Health Canada (HC)
    • Jeff Skene · Senior Executive Director, Health Canada (HC)
    • Jean Francois Eddy · Analyst, Health Canada (HC)
    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers

    Official report

    • Loris Mirella · Director, Global Affairs Canada (GAC)
    • Arianne Reza · Deputy Minister, Public Services and Procurement Canada (PSPC)
    • Joelle Paquette · Associate Assistant Deputy Minister, Public Services and Procurement Canada (PSPC)
    • Gabrielle Dolgoy · Senior Trade Policy Officer, Global Affairs Canada (GAC)
    Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations Read more

    Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Official report

    • Marjorie Michel · Minister of Health, Health Canada (HC)
    • Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
    • Shalene Curtis-Micallef · Deputy Minister of Health, Health Canada (HC)
    Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector. Read more

    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations

    Official report

  • and 2 more
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    • Guillaume Couillard · Director General, Patented Medicine Prices Review Board (PMPRB)
    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers Read more

    Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.

    Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Official report

    • Pamela Aung-Thin · ADM, Health Canada (HC)
    • David Lee · Chief Regulatory Officer, Health Canada (HC)
    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers

    Official report

    • Karim Bardeesy · MP
    • Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector. Read more

    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers

    Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Official report

    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations Read more

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector.

    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers

    Official report

    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Pamela Aung-Thin · ADM, Health Canada (HC)
    • Daniel MacDonald · ADM Pharmaceutical Strategy, Health Canada (HC)
    Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers Read more

    Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.